Brief: 9 Meters Biopharma Announces Successful Pre-Ind Meeting With FDA Regarding Its Gip Antagonist Nm-136 For Obesity
April 5 (Reuters) - 9 Meters Biopharma Inc NMTR.O :
* 9 METERS BIOPHARMA ANNOUNCES SUCCESSFUL PRE-IND MEETING
WITH FDA
REGARDING ITS GIP ANTAGONIST NM-136 FOR OBESITY
Further company coverage: NMTR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 9 Meters Biopharma
See all newsIllumina cuts annual profit forecast as biotech funding woes linger (updated)
Illumina cuts annual profit forecast
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
9 Meters Biopharma falls after filing for bankruptcy protection